Pharmacogenomics in drug development: societal and technical aspects

被引：7

作者：

Bartfai, T ^{[1
]}

机构：

[1] Scripps Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA

来源：

PHARMACOGENOMICS JOURNAL | 2004年 / 4卷 / 04期

关键词：

D O I：

10.1038/sj.tpj.6500249

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：226 / 232

页数：7

共 30 条

[1] Molecular genetic analysis of the α-synuclein and the parkin gene in Parkinson's disease in Finland [J].

Autere, JM ;

Hiltunen, MJ ;

Mannermaa, AJ ;

Jäkälä, PA ;

Hartikainen, PH ;

Majamaa, K ;

Alafuzoff, I ;

Soininen, HS .

EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (05) :479-483

[2] Pharmacogenomics in schizophrenia: the quest for individualized therapy [J].

Basile, VS ;

Masellis, M ;

Potkin, SG ;

Kennedy, JL .

HUMAN MOLECULAR GENETICS, 2002, 11 (20) :2517-2530

[3] What can we learn from Herceptin® trials in metastatic breast cancer? [J].

Bell, R .

ONCOLOGY, 2002, 63 :39-46

[4] Pharmacogenomics for the treatment of dementia [J].

Cacabelos, R .

ANNALS OF MEDICINE, 2002, 34 (05) :357-379

[5] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].

CORDER, EH ;

SAUNDERS, AM ;

STRITTMATTER, WJ ;

SCHMECHEL, DE ;

GASKELL, PC ;

SMALL, GW ;

ROSES, AD ;

HAINES, JL ;

PERICAKVANCE, MA .

SCIENCE, 1993, 261 (5123) :921-923

[6] Impact of genomics on drug discovery and clinical medicine [J].

Emilien, G ;

Ponchon, M ;

Caldas, C ;

Isacson, O ;

Maloteaux, JM .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2000, 93 (07) :391-423

[7]

Freund Carol L, 2002, Am J Pharmacogenomics, V2, P273, DOI 10.2165/00129785-200202040-00007

[8] An Icelandic saga on a centralized healthcare database and democratic decision making [J].

Gulcher, J ;

Stefansson, K .

NATURE BIOTECHNOLOGY, 1999, 17 (07) :620-620

[9] Ethics of population genomics research [J].

Gulcher, JR ;

Stefansson, K .

NATURE, 1999, 400 (6742) :307-308

[10]

HALDANE, 1954, BIOCH GENETICS

← 1 2 3 →